PRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Prenetics Global Ltd (PRE) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. While the company has shown significant revenue growth and has shifted focus to its IM8 brand, the lack of strong technical signals, neutral trading sentiment, and ongoing financial losses suggest a cautious approach. Holding the stock or waiting for further clarity on profitability and technical improvements would be more prudent.
The MACD is below 0 and negatively contracting, indicating weak momentum. RSI is neutral at 31.726, and moving averages are converging, showing no clear trend. Key support is at 17.313, and resistance is at 19.238. The stock has a 60% chance of a -0.4% decline in the next day and a 2.27% increase in the next week, but the long-term trend remains uncertain.
The company has divested non-core assets, generating over $150M in proceeds and simplifying its operations. Its IM8 brand has scaled rapidly to over $100M in revenue, and analysts have initiated coverage with buy ratings and high price targets ($29 and $36).
EPS remains negative at -1.
Technical indicators do not suggest a strong upward trend, and there is no recent news or significant trading activity from insiders or hedge funds.
In Q4 2025, revenue increased by 248.57% YoY to $36.56M, and gross margin improved to 59.47%. However, the company remains unprofitable, with a net income of -$28.1M and an EPS of -1.75, despite a YoY improvement of 72.05% and 36.72%, respectively.
Analysts from Lake Street and Roth Capital have initiated coverage with buy ratings and price targets of $29 and $36, citing the company's focus on its IM8 brand and its growth potential. However, they acknowledge past struggles and the need for further operational improvements.
